STOCK TITAN

Johnson & Johnson (JNJ) CEO Duato exercises 123K options and sells 123K shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Johnson & Johnson CEO and Chairman Joaquin Duato reported a series of transactions on August 13, 2026. He exercised 123,291 Employee Stock Options at an exercise price of $115.67 per share, receiving an equal number of common shares. On the same date he sold 20,976 shares at $262.00 per share and 102,315 shares at $261.00 per share. Indirect holdings reported include 1,018 shares held through a 401(k) plan and 30,852 shares held by his spouse, with the 401(k) amount including shares accrued via dividend reinvestment under the Johnson & Johnson Savings Plan.

Positive

  • None.

Negative

  • None.
Insider Duato Joaquin
Role CEO and Chairman of the Board
Sold 123,291 shs ($32.20M)
Approx. gross sale proceeds $32.20M
Approx. exercise cost $14.26M
Approx. pre-tax spread $17.94M
Type Security Shares Price Value
Exercise Employee Stock Options (Right to Buy) F2 123,291 $0.00 $0.00
Exercise Common Stock 123,291 $115.67 $14.26M
Sale Common Stock 20,976 $262.00 $5.50M
Sale Common Stock 102,315 $261.00 $26.70M
holding Common Stock F1 -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Employee Stock Options (Right to Buy) — 0 shares (Direct); Common Stock — 275,967 shares (Direct); Common Stock — 1,018 shares (Indirect, By 401k); Common Stock — 30,852 shares (Indirect, By spouse)
Footnotes (2)
  1. F1. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/31/2026).
  2. F2. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Options Exercised 123,291 shares Employee Stock Options exercised on August 13, 2026
Option Exercise Price $115.67 per share Exercise price of Employee Stock Options converting into common stock
Sale Block 1 20,976 shares at $262.00 Common stock sale on August 13, 2026
Sale Block 2 102,315 shares at $261.00 Common stock sale on August 13, 2026
Indirect 401(k) Holdings 1,018 shares Indirect ownership via Johnson & Johnson Savings Plan
Spousal Holdings 30,852 shares Indirect ownership reported as held by spouse
Option Expiration Date February 13, 2027 Expiration of Employee Stock Options exercised
Employee Stock Options (Right to Buy) financial
"security_title: Employee Stock Options (Right to Buy)"
Long-Term Incentive Plan financial
"Awarded under Issuer's Long-Term Incentive Plan."
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
dividend reinvestment financial
"Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
Johnson & Johnson Savings Plan financial
"under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date"

FAQ

What did JNJ CEO Joaquin Duato report in this Form 4?

Joaquin Duato reported exercising 123,291 stock options at $115.67 per share and selling 123,291 common shares in two blocks at $262.00 and $261.00 per share, along with updated indirect holdings.

How many Johnson & Johnson (JNJ) stock options did Joaquin Duato exercise?

He exercised 123,291 Employee Stock Options on August 13, 2026 at an exercise price of $115.67 per share, converting them into an equal number of Johnson & Johnson common shares before subsequent sales reported the same day.

How many Johnson & Johnson (JNJ) shares did Joaquin Duato sell and at what prices?

He sold 20,976 shares at $262.00 per share and 102,315 shares at $261.00 per share on August 13, 2026, following the exercise of stock options into common shares.

What indirect Johnson & Johnson (JNJ) holdings does Joaquin Duato report?

He reports 1,018 shares held indirectly through a 401(k) plan and 30,852 shares held indirectly by his spouse. The 401(k) position includes shares accrued via dividend reinvestment in the Johnson & Johnson Savings Plan.

What are the terms of the Johnson & Johnson (JNJ) stock options exercised by Joaquin Duato?

The Employee Stock Options for 123,291 shares had an exercise price of $115.67 per share, were awarded under the issuer’s Long-Term Incentive Plan, and vest and become exercisable on the third anniversary of the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Duato Joaquin

(Last)(First)(Middle)
ONE JOHNSON & JOHNSON PLAZA

(Street)
NEW BRUNSWICK NEW JERSEY 08933

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO and Chairman of the Board
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/13/2026M123,291A$115.67399,258D
Common Stock08/13/2026S20,976D$262378,282D
Common Stock08/13/2026S102,315D$261275,967D
Common Stock1,018(1)IBy 401k
Common Stock30,852IBy spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Options (Right to Buy)$115.6708/13/2026M123,29102/14/2020(2)02/13/2027Common Stock123,291$00D
Explanation of Responses:
1. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/31/2026).
2. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Remarks:
/s/ Joleen Morgan, as attorney-in-fact for Joaquin Duato08/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)